Invivyd Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	53.01	49.13	47.04	36.52	5.5
Research & Development	162.62	158.66	179.21	182.89	37.7
Operating Expenses	215.63	207.78	226.26	219.41	43.2
Operating Income	-215.63	-207.78	-226.26	-219.41	-43.2
Interest & Investment Income	8.8	7.3	3.9	1.7	-
Other Non Operating Income (Expenses)	0.06	0.02	-17.36	-0.15	0.01
EBT Excluding Unusual Items	-206.77	-200.47	-239.72	-217.86	-43.19
Gain (Loss) on Sale of Investments	4.1	6.8	2.8	-1.43	-
Pretax Income	-206.82	-198.64	-241.32	-226.79	-111.98
Net Income	-206.82	-198.64	-241.32	-226.79	-111.98
Net Income to Common	-206.82	-198.64	-241.32	-226.79	-111.98
Shares Outstanding (Basic)	111	110	108	43	4
Shares Outstanding (Diluted)	111	110	108	43	4
Shares Change (YoY)	2.52%	1.16%	154.02%	1081.14%	-
EPS (Basic)	-1.86	-1.81	-2.23	-5.32	-31.03
EPS (Diluted)	-1.86	-1.81	-2.23	-5.32	-31.03
Free Cash Flow	-182.33	-173.78	-221.69	-184.82	-24.98
Free Cash Flow Per Share	-1.64	-1.59	-2.05	-4.34	-6.92
EBITDA	-215.14	-207.3	-226.22	-219.41	-
D&A For EBITDA	0.48	0.48	0.04	0	-
EBIT	-215.63	-207.78	-226.26	-219.41	-43.2

Source: S&P Capital IQ. Standard template.